B&I Capital AG grew its position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 16.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 263,270 shares of the real estate investment trust's stock after purchasing an additional 37,980 shares during the quarter. Omega Healthcare Investors makes up 3.2% of B&I Capital AG's investment portfolio, making the stock its 10th largest position. B&I Capital AG owned approximately 0.10% of Omega Healthcare Investors worth $9,965,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of OHI. Jones Financial Companies Lllp raised its position in shares of Omega Healthcare Investors by 60.9% during the 4th quarter. Jones Financial Companies Lllp now owns 9,578 shares of the real estate investment trust's stock worth $363,000 after acquiring an additional 3,624 shares in the last quarter. SRS Capital Advisors Inc. boosted its stake in Omega Healthcare Investors by 146.2% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,699 shares of the real estate investment trust's stock valued at $64,000 after acquiring an additional 1,009 shares in the last quarter. Metis Global Partners LLC grew its holdings in shares of Omega Healthcare Investors by 11.4% during the fourth quarter. Metis Global Partners LLC now owns 29,557 shares of the real estate investment trust's stock worth $1,119,000 after purchasing an additional 3,017 shares during the last quarter. Providence First Trust Co purchased a new position in shares of Omega Healthcare Investors during the fourth quarter worth about $246,000. Finally, US Bancorp DE increased its position in shares of Omega Healthcare Investors by 1.9% during the fourth quarter. US Bancorp DE now owns 16,173 shares of the real estate investment trust's stock worth $612,000 after purchasing an additional 309 shares in the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.
Omega Healthcare Investors Stock Performance
Omega Healthcare Investors stock traded down $1.55 during trading hours on Thursday, reaching $36.00. 2,516,909 shares of the stock were exchanged, compared to its average volume of 1,644,441. The stock has a market cap of $10.15 billion, a P/E ratio of 23.23, a P/E/G ratio of 1.09 and a beta of 0.99. The firm's 50 day moving average is $37.17 and its 200 day moving average is $39.02. The company has a debt-to-equity ratio of 1.02, a quick ratio of 7.07 and a current ratio of 7.07. Omega Healthcare Investors, Inc. has a 52-week low of $29.66 and a 52-week high of $44.42.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share for the quarter, beating analysts' consensus estimates of $0.41 by $0.33. Omega Healthcare Investors had a return on equity of 9.71% and a net margin of 38.65%. Analysts predict that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.
Omega Healthcare Investors Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th were issued a $0.67 dividend. The ex-dividend date was Monday, February 10th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 7.44%. Omega Healthcare Investors's dividend payout ratio is presently 172.90%.
Analysts Set New Price Targets
A number of analysts recently issued reports on OHI shares. JMP Securities reissued a "market perform" rating on shares of Omega Healthcare Investors in a research report on Friday, February 7th. Royal Bank of Canada raised their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a research report on Monday, November 11th. BMO Capital Markets raised shares of Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 target price on the stock in a report on Monday, December 9th. Finally, Mizuho increased their price target on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a "neutral" rating in a research note on Thursday, December 5th. Five investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $41.67.
Check Out Our Latest Analysis on Omega Healthcare Investors
About Omega Healthcare Investors
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Further Reading
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
